If you’ve searched for a direct answer to this question, you’ve probably found contradictory articles depending on when they were written. Here is the current-to-2026 picture. Restoration Recovery is an outpatient addiction clinic with a location in Ringgold, Georgia, plus three clinics in Southeast Tennessee, and we treat kratom and 7-OH dependence. This article is factual reporting on the legal landscape as of October 2026. It is not legal advice; if you have a specific legal question, consult a Georgia attorney. What we can speak to clinically is what treatment for kratom or 7-OH dependence looks like, and how it is unaffected by the regulatory questions playing out in Atlanta.
Georgia status · legal + regulated (21+)
Kratom & 7-OH are legal but regulated in Georgia
Legal at 21+Kratom and 7-OH are legal for adults 21 and older in Georgia, sold through regulated retail channels under the 2019 Kratom Consumer Protection Act as amended by HB181 (effective January 1, 2025). Under that law, retailers must verify age and keep products behind the counter, products must be labeled and lab-tested, and violations carry civil penalties; consumers do not face criminal charges. HB757, a 2025 product-registration bill, stalled after its second reading and never became law. HB968, introduced in 2026, would have replaced that framework with a Schedule I ban; it died when the session ended without a floor vote. Federal 7-OH action is on a separate track: 7-OH is still federally unscheduled. On July 6, 2026 the DEA published a notice of intent to temporarily place 7-OH above a specified threshold in Schedule I. On October 14, 2026 it replaced that notice with a new one that covers 7-OH and mitragynine pseudoindoxyl above a new threshold. As of October 2026 no order has been issued.
Legal status
Legal for 21+
Sold through regulated retail. Violations carry civil penalties.
Framework
HB181 (regulated)
Amends the 2019 Kratom Consumer Protection Act.
2026 ban bill
HB968 died
Criminalization proposal (Schedule I) — no floor vote before the session ended.
Federal 7-OH
Unscheduled
FDA recommended Schedule I; DEA notice of intent July 6, 2026, replaced October 14, 2026; no order yet.
Kratom is legal for adults aged 21 and older in Georgia under the state’s 2019 Kratom Consumer Protection Act, as amended by HB181 effective January 1, 2025. The legal framework is regulatory rather than prohibitive: kratom and 7-OH products are sold through regulated retail channels, subject to age verification, labeling, laboratory testing, and display requirements. Violations carry civil penalties and product-seizure authority rather than criminal exposure for consumers. This framework could change in a future session. HB968, introduced in the 2026 session, would have reclassified mitragynine and 7-OH as Schedule I controlled substances and repealed portions of the existing framework, but it died when the session ended without a floor vote.
How Georgia’s kratom law evolved
Georgia passed a consumer-protection act in 2019, then tightened it with HB181. Two later bills never became law: HB757, a 2025 product-registration bill, and HB968, which would have banned kratom and died in 2026. Here is the sequence, and where it stands today.
2019 · Done
Kratom Consumer Protection Act
Georgia enacted its Kratom Consumer Protection Act, establishing kratom as a legal, regulated product rather than a controlled substance.
Signed May 2, 2024 · Effective Jan 1, 2025 · Done
HB181 — the current regulatory regime
Gov. Brian Kemp signed HB181 on May 2, 2024, effective January 1, 2025. It raised the purchase age to 21, added behind-counter display, labeling, and third-party-testing requirements, and capped 7-OH at 2 percent of total alkaloid content.
2025 session · stalled
HB757 — product registration bill
HB757, a 2025 bill to require registration of kratom products and sworn certification of compliance, stalled after its second reading in March 2025 and never became law.
2026 session · died
HB968 — Schedule I criminalization proposal
HB968 would have classified mitragynine and 7-hydroxymitragynine as Schedule I controlled substances and repealed portions of the existing framework, turning possession, sale, and distribution into criminal offenses. It died when the 2026 session ended: a House committee reported it by substitute on March 6, 2026, and neither chamber held a floor vote.
If a future ban bill passed
Georgia would move to the banned column
A bill like HB968 would shift Georgia from its current regulated-market status to a full prohibition, joining Alabama, Tennessee (banned July 1, 2026), and seven other states. As of October 2026 this has not happened.
How Georgia regulates kratom (HB181)
Georgia Governor Brian Kemp signed HB181 into law on May 2, 2024, with provisions taking effect January 1, 2025. The law amended the 2019 Kratom Consumer Protection Act. Together they define what a legal kratom sale in Georgia looks like:
HB181 · Regulated
Age verification (21+) Minimum purchase age raised from 18 to 21. Retailers must verify age; selling to anyone under 21 is a civil violation with fines starting at $1,000.HB181 · Regulated
Behind-counter display Products must be kept behind a display counter accessible only to employees, or in a secured display requiring employee assistance. Open-shelf display is no longer permitted.HB181 · Regulated
Labeling standards Every product must disclose mitragynine and 7-OH content as separate line items, plus serving size, batch/lot, expiration date, and a 21-plus warning. Labeling violations carry fines up to $2,500.HB181 · Regulated
7-OH concentration cap Caps 7-hydroxymitragynine at 2 percent of total alkaloid content, and prohibits synthetic alkaloid additives and adulteration with non-kratom substances.HB181 · Regulated
Third-party testing Products must be lab-tested for mitragynine, 7-OH, heavy metals, pesticides, bacteria, and mold. Certificates of Analysis must be available on request or via scannable codes.HB968 — the Schedule I criminalization proposal
HB968, introduced in the 2026 Georgia General Assembly session, would have criminalized kratom instead of regulating it. It proposed to classify mitragynine and 7-hydroxymitragynine as Schedule I controlled substances under Georgia’s drug statute and repeal portions of the existing Kratom Consumer Protection Act. The bill died when the session ended without a floor vote in either chamber.
2026 bill · died without a vote
What HB968 would have done — and where it stands
If it had been enacted, HB968 would have made possession, manufacture, sale, and distribution of mitragynine or 7-hydroxymitragynine criminal offenses rather than civil violations. Schedule I classification at the state level carries the same general framework as Alabama’s existing treatment of kratom: possession becomes a felony offense with potential prison time and substantial fines, and the product category becomes unavailable through legal retail channels.
HB968 died when the 2026 session ended. Its last recorded action was a House committee report by substitute on March 6, 2026; neither chamber held a floor vote. A similar bill could be filed in a future session.
Ten states now fully ban kratom: Alabama, Arkansas, Indiana, Vermont, Wisconsin, Louisiana (banned August 2025), Connecticut (banned 2026), Kansas (banned 2026), Tennessee (banned July 1, 2026), and Massachusetts (temporary emergency placement, August 2026). Rhode Island was on the banned list until April 1, 2026, when a new regulatory framework took effect — the first U.S. state to reverse a kratom ban. Tennessee’s HB1649/SB1656, which criminalizes kratom statewide, passed both chambers on April 16, 2026 and was signed by Governor Bill Lee on May 7, 2026 (Public Chapter 950), taking effect July 1, 2026, as documented in our companion article on Tennessee kratom law.
Federal 7-OH scheduling is a separate track
State law is only part of the picture. At the federal level, kratom itself remains unscheduled under the Controlled Substances Act, but the status of concentrated 7-hydroxymitragynine products is actively in motion on a separate timeline.
- July 29, 2025: the FDA formally recommended to the DEA that concentrated 7-OH products be scheduled as Schedule I under the Controlled Substances Act. The recommendation targeted 7-OH concentrates specifically — tablets, gummies, drink mixes, and shots with elevated 7-OH concentrations — not natural whole-leaf kratom.
- DEA notice of intent: on July 6, 2026 the DEA published a notice of intent to temporarily place 7-OH above a specified threshold in Schedule I. On October 14, 2026 it replaced that notice with a new one that covers 7-OH and mitragynine pseudoindoxyl above a new threshold. As of October 2026 no temporary scheduling order has been issued, so 7-OH is still not federally scheduled; permanent scheduling would still require standard rulemaking with a public-comment period.
- If the order is published: products above the threshold would become illegal to manufacture, sell, or possess nationwide, regardless of what any individual state does. The new notice says the DEA will not publish an order before November 13, 2026.
Our companion explainer on 7-OH versus whole-leaf kratom covers the pharmacology and regulatory distinction in more depth, and our federal tracker, Is 7-OH Banned Yet? federal tracker, follows the FDA/DEA scheduling status as it develops.
What this means for Georgia residents dependent on kratom or 7-OH
This is the part of the article that matters most if you are reading this page because you are struggling to stop using kratom or 7-OH, or because someone you care about is. The legal status of kratom products does not affect whether treatment is available, effective, or covered by insurance. The medications used for kratom MAT (buprenorphine-based: Suboxone, Sublocade, Brixadi) are controlled substances with their own FDA-approved indication for opioid use disorder. The clinical protocol, insurance coverage, and 42 CFR Part 2 confidentiality protections stay the same whether or not Georgia or the federal government acts.
Kratom’s primary active alkaloids, mitragynine and 7-hydroxymitragynine, bind to the same mu-opioid receptors that fentanyl, heroin, and prescription opioids act on. Although kratom is not itself a classical opioid, that receptor activity means the same medication-assisted treatment protocol used for opioid use disorder is clinically effective for kratom dependence. Buprenorphine, the active medication in Suboxone, Sublocade, and Brixadi, is a partial opioid agonist that relieves kratom withdrawal, suppresses craving, and provides a stable transition off kratom products over weeks rather than days.
Georgia Medicaid covers medication-assisted treatment for opioid use disorder through the Georgia Families managed care program, including the same buprenorphine-based medications used for kratom dependence. Georgia’s Medicaid care management organization (CMO) lineup can change as the state settles its next round of contracts, so members should call their specific plan or our intake team to confirm in-network status before scheduling. Restoration Recovery’s Ringgold clinic is in Catoosa County, serving patients from across North Georgia including Catoosa, Walker, Whitfield, Murray, Dade, Gordon, and Chattooga counties. The three Tennessee-side clinics also see Georgia residents routinely, particularly from counties closest to the state line; see our Find Treatment Near You directory for the broader map.
Start treatment this week
Buprenorphine-based treatment for kratom and 7-OH dependence is available now at our Ringgold, GA clinic and three Southeast Tennessee locations. Same-week appointments, most insurance accepted, including Georgia Medicaid through the Georgia Families program.
Georgia kratom law FAQ
Is kratom legal in Georgia in 2026?+
What does HB181 require for Georgia kratom retailers?+
Would HB968 make kratom illegal in Georgia?+
Does legal status affect treatment for kratom dependence?+
Is there an age limit to buy kratom in Georgia?+
Where to check current status
Legislation can shift during a legislative session. For the most current status of Georgia bills, the Georgia General Assembly maintains bill-tracking pages for each active bill at legis.ga.gov. Independent trackers like BillTrack50 and LegiScan also show committee actions, voting records, and full bill text. For the federal 7-OH picture, FDA and DEA press releases and notices in the Federal Register are the authoritative sources. We update our Tennessee kratom law article and this Georgia companion as bill status changes meaningfully.
This article is published for patient information only. It is not legal advice. If you have a specific legal question about your situation, consult a Georgia attorney licensed to practice in your jurisdiction.
If you are ready to stop
Whatever the Georgia General Assembly does with kratom in a future session, the clinical reality for kratom and 7-OH dependence is stable. Buprenorphine-based MAT works, same-week appointments are available at our Ringgold clinic and our three Southeast Tennessee locations, and most insurance plans (including Georgia Medicaid through the Georgia Families program) cover treatment. Call 423-498-2000 or submit a contact request when you are ready.
Related reading
Tennessee
Is kratom legal in Tennessee in 2026? →Alabama
Alabama kratom laws 2026: Schedule I classification →Federal tracker
Is 7-OH banned yet? 2026 FDA/DEA status →Legal tracker
Kratom laws by state 2026: complete U.S. tracker →Drug identity
7-OH vs. kratom: why concentrated products are different →Treatment
Kratom & 7-OH addiction treatment overview →
